SRTS (STOCKS)
Sensus Healthcare, Inc
$4.461000
+0.031000 (+0.70%)
Prev close: $4.430000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Joseph C. Sardano
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $73.44M
- Employees
- 54
- P/E (TTM)
- -9.37
- P/B (TTM)
- 1.52
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.19 | $-0.07 | -0.1186 | -166.11% |
|
Sep 2025 (Q3)
|
$-0.06 | $-0.10 | +0.0369 | +38.08% |
|
Jun 2025 (Q2)
|
$-0.06 | $0.03 | -0.0865 | -326.42% |
|
Mar 2025 (Q1)
|
$-0.16 | $0.03 | -0.1947 | -561.10% |
Financial Statements
| Revenues | $27.48M |
| Benefits Costs and Expenses | $37.11M |
| Cost Of Revenue | $15.62M |
| Costs And Expenses | $37.11M |
| Gross Profit | $11.87M |
| Operating Expenses | $22.17M |
| Selling, General, and Administrative Expenses | $7.87M |
| Depreciation and Amortization | $400.00K |
| Research and Development | $7.78M |
| Other Operating Expenses | $6.12M |
| Operating Income/Loss | -$10.31M |
| Income/Loss From Continuing Operations After Tax | -$7.72M |
| Income/Loss From Continuing Operations Before Tax | -$9.62M |
| Income Tax Expense/Benefit | -$1.91M |
| Income Tax Expense/Benefit, Deferred | -$1.88M |
| Interest Income/Expense After Provision For Losses | $683.00K |
| Interest Income/Expense Operating, Net | $683.00K |
| Net Income/Loss | -$7.72M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.72M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.72M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$0.47 |
| Diluted Earnings Per Share | -$0.47 |
| Basic Average Shares | 16,326,937 |
| Diluted Average Shares | 16,326,937 |
| Assets | $53.04M |
| Current Assets | $45.89M |
| Inventory | $14.56M |
| Prepaid Expenses | $1.52M |
| Other Current Assets | $29.81M |
| Noncurrent Assets | $7.15M |
| Fixed Assets | $1.98M |
| Other Non-current Assets | $5.17M |
| Liabilities | $4.94M |
| Current Liabilities | $4.72M |
| Noncurrent Liabilities | $219.00K |
| Equity | $48.10M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $48.10M |
| Liabilities And Equity | $53.04M |
| Net Cash Flow From Operating Activities | $528.00K |
| Net Cash Flow From Operating Activities, Continuing | $528.00K |
| Net Cash Flow From Investing Activities | -$196.00K |
| Net Cash Flow From Investing Activities, Continuing | -$196.00K |
| Net Cash Flow From Financing Activities | -$305.00K |
| Net Cash Flow From Financing Activities, Continuing | -$305.00K |
| Net Cash Flow | $27.00K |
| Net Cash Flow, Continuing | $27.00K |
| Comprehensive Income/Loss | -$7.72M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.72M |
| Other Comprehensive Income/Loss | $0.00 |